An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Veterans Day: Recognizing the Hearing Health Challenges of Those Who Served
Military service can come with lasting effects on hearing health. Exposure to gunfire, explosions, aircraft, heavy equipment, and other hazardous noise puts service members at…
Universal Screening for Congenital Cytomegalovirus (cCMV) Doubles the Detection in Newborns
cCMV is the most common nongenetic cause of hearing loss and developmental delays, with the most recent statistics reporting that 1 in every 200 live…
Cardiorespiratory Fitness and Speech Perception
The American Academy of Audiology (2026) recently published a review of an updated report regarding aerobic physical activity levels in US adults. In this report,…



